Trial Profile
An Open Label, Single-Centre, Phase II Study for Radiosensitization of AVASTIN(R) (Bevacizumab) With Stereotactic Body Radiotherapy (SBRT) for Colorectal Liver Metastasis (SBRT Avastin)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Pharmacodynamics; Proof of concept
- Acronyms SBRT-Avastin
- 29 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 13 Apr 2012 New trial record